全文获取类型
收费全文 | 4960728篇 |
免费 | 398699篇 |
国内免费 | 21094篇 |
专业分类
耳鼻咽喉 | 70203篇 |
儿科学 | 155189篇 |
妇产科学 | 130576篇 |
基础医学 | 737505篇 |
口腔科学 | 138429篇 |
临床医学 | 455451篇 |
内科学 | 897302篇 |
皮肤病学 | 115871篇 |
神经病学 | 415163篇 |
特种医学 | 195307篇 |
外国民族医学 | 1212篇 |
外科学 | 741499篇 |
综合类 | 166235篇 |
现状与发展 | 49篇 |
一般理论 | 2820篇 |
预防医学 | 423128篇 |
眼科学 | 117221篇 |
药学 | 355603篇 |
170篇 | |
中国医学 | 21416篇 |
肿瘤学 | 240172篇 |
出版年
2021年 | 59733篇 |
2019年 | 60696篇 |
2018年 | 76917篇 |
2017年 | 59970篇 |
2016年 | 66002篇 |
2015年 | 80019篇 |
2014年 | 115842篇 |
2013年 | 182627篇 |
2012年 | 146324篇 |
2011年 | 153105篇 |
2010年 | 136413篇 |
2009年 | 136982篇 |
2008年 | 138001篇 |
2007年 | 146809篇 |
2006年 | 154159篇 |
2005年 | 147697篇 |
2004年 | 146392篇 |
2003年 | 135719篇 |
2002年 | 125062篇 |
2001年 | 189577篇 |
2000年 | 186882篇 |
1999年 | 167757篇 |
1998年 | 75802篇 |
1997年 | 70913篇 |
1996年 | 68829篇 |
1995年 | 64521篇 |
1994年 | 58443篇 |
1993年 | 54144篇 |
1992年 | 124153篇 |
1991年 | 118722篇 |
1990年 | 113190篇 |
1989年 | 109956篇 |
1988年 | 101991篇 |
1987年 | 100315篇 |
1986年 | 94769篇 |
1985年 | 92497篇 |
1984年 | 76386篇 |
1983年 | 67463篇 |
1982年 | 51779篇 |
1981年 | 47919篇 |
1980年 | 44985篇 |
1979年 | 67788篇 |
1978年 | 53458篇 |
1977年 | 46648篇 |
1976年 | 43512篇 |
1975年 | 43259篇 |
1974年 | 49396篇 |
1973年 | 47532篇 |
1972年 | 44629篇 |
1971年 | 41031篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
42.
43.
44.
45.
46.
47.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
48.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
49.
目的探讨C型凝集素受体Dectin-2在烟曲霉菌感染中的作用及机制。方法用紫外线灭活的烟曲霉菌膨胀态分生孢子刺激野生型(wild type, WT)和Dectin-2缺失(Clec4n-/-)小鼠骨髓来源的巨噬细胞(bone marrow derived macrophages, BMDMs)。刺激20min及40min后,利用Western印迹法检测BMDMs中脾酪氨酸激酶(spleen tyrosine kinase, Syk)和核转录因子κB抑制因子(inhibitor-κB, IκBα)的磷酸化水平。刺激16h后,利用酶联免疫吸附法(enzyme-linked immunosorbent assay, ELISA)检测BMDMs细胞上清液中IL-6、TNF-α和IL-12p40的水平。另一方面,利用压舌感染的方法在WT和Clec4n-/-小鼠中构建烟曲霉菌肺部感染模型。感染2d后,统计小鼠整个肺脏荷菌量,并检测肺脏匀浆液中IL-6和IL-12p40水平。结果体外试验提示,烟曲霉菌刺激后,Dectin-2缺失的BMDMs中Syk和IκBα的磷酸化水平及IL-6、TNF-α和IL-12p40水平显著下降(P<0.05)。体内试验发现,烟曲霉菌感染后,Dectin-2缺失小鼠中肺脏荷菌量显著升高(P<0.05),肺脏匀浆液内IL-6、IL-12p40水平显著降低(P<0.05)。结论C型凝集素受体Dectin-2激活烟曲霉菌诱导的NF-κB信号通路并介导促炎细胞因子的产生,可在小鼠肺烟曲霉菌病动物模型中发挥保护性作用。 相似文献
50.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献